Compare TruAlt Bioenergy with Similar Stocks
Stock DNA
Commodity Chemicals
INR 3,518 Cr (Small Cap)
24.00
39
0.00%
0.89
10.11%
2.50
Total Returns (Price + Dividend) 
TruAlt Bioenergy for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

TruAlt Bioenergy Ltd Technical Momentum Shifts Amid Sideways Trend
TruAlt Bioenergy Ltd, a small-cap player in the Commodity Chemicals sector, has experienced a notable shift in price momentum and technical indicators, signalling a transition from a mildly bullish trend to a sideways movement. This change comes amid a decline in the stock price and a downgrade in its Mojo Grade, reflecting growing investor caution despite some positive returns over the past month.
Read full news article
TruAlt Bioenergy Ltd is Rated Sell
TruAlt Bioenergy Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 March 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 11 April 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
TruAlt Bioenergy Ltd Technical Momentum Shifts Signal Mild Bullish Outlook
TruAlt Bioenergy Ltd, a small-cap player in the Commodity Chemicals sector, has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a slight dip in the daily price, key technical indicators suggest improving market sentiment, offering a nuanced outlook for investors navigating this evolving landscape.
Read full news article Announcements 
Disclosure Under Regulation 30(5) Of SEBI (LODR) Regulation 2015
30-Mar-2026 | Source : BSEPlease find attached intimation.
Closure of Trading Window
27-Mar-2026 | Source : BSEPlease find attached intimation regarding closure of Trading window.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
13-Feb-2026 | Source : BSETranscript of the Earnings Conference Call pertaining to the Unaudited Financial Results for the quarter and nine months ended December 31 2025
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 5 Schemes (4.35%)
Held by 14 FIIs (0.93%)
Vijaykumar Nirani (17.88%)
Rakeshkumar Viththalbhai Patel (3.82%)
14.43%
Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is 572.88% vs -64.45% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is 254.43% vs -1,42,600.00% in Sep 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Not Applicable: The company has declared_date for only one period
Not Applicable: The company has declared_date for only one period
Nine Monthly Results Snapshot (Standalone) - Dec'25
Not Applicable: The company has declared_date for only one period
Not Applicable: The company has declared_date for only one period
Annual Results Snapshot (Standalone) - Mar'25
Not Applicable: The company has declared_date for only one period
Not Applicable: The company has declared_date for only one period






